Deal offers developers in cell and gene therapy streamlined access to plasmid DNA and viral vector manufacturing in new, flexible end-to-end serviceLyon and Besançon, France, October 25, 2022 – ABL, a pure play Contract Development and Manufacturing Organization (CDMO) with specialized expertise in the development a...